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Abstract.  Receptors for bacterial N-formyl peptides 
are instrumental for neutrophil chemotactic locomo- 
tion and activation at sites of infection. As regulatory 
mechanisms for signal transduction, both rapid cou- 
pling of the occupied receptor to cytoskeletal compo- 
nents, and receptor lateral redistribution, have been 
suggested (Jesaitis et al.,  1986, 1989). 
To compare the distribution and lateral diffusion of 
the nonactivated and activated neutrophil N-formyl- 
peptide receptor, before internalization, we used a new 
fluorescent N-formyl-peptide receptor antagonist, tert- 
butyloxycarbonyl-Phe(D)-Leu-Phe(D)-Leu-Phe-OH 
(Boc-FLFLE 0.1-1 /~M), and the fluorescent receptor 
agonist formyl-Nle-Leu-Phe-Nle-Tyr-Lys  (fnLLFnLYK, 
0.1-1 /~M). Fluorescent Boc-FLFLF did not elicit an 
oxidative burst in the neutrophil at 37°C, as assessed 
by chemiluminescence and reduction of p-nitroblue 
tetrazolium chloride, but competed efficiently both 
with formyl-methionyl-leucyl-phenylalanine  (fMLF) 
and fnLLFnLYK. It was not internalized, as evidenced 
by confocal microscopy and acid elution of surface 
bound ligand. 
The lateral mobility characteristics of the neutrophil 
fMLF receptor were investigated with the technique of 
FRAE The diffusion coefficient (D) was similar for 
antagonist- and agonist-labeled receptors (D =  5  x 
10  -1° cmE/s), but the fraction of mobile receptors was 
significantly lower in agonist- compared to antagonist- 
labeled cells, ~40%  in contrast to ,x,60%. 
This reduction in receptor mobile fraction was 
slightly counteracted, albeit not significantly, by dihy- 
drocytochalasin B (dhcB, 5/zM). 
To block internalization of agonist-labeled receptors, 
receptor mobility measurements were done at 14°C. 
At this temperature, confocal microscopy revealed 
clustering of receptors in response to agonist binding, 
compared to a more uniform receptor distribution in 
antagonist-labeled cells. The pattern of agonist-induced 
receptor clustering was less apparent after dhcB 
treatment. 
To summarize, this work shows that activated N-for- 
myl peptide receptors aggregate and immobilize in the 
plane of the neutrophil plasma membrane before in- 
ternalization, a process that is affected, but not signifi- 
cantly reversed, by cytochalasin. The results are con- 
sistent with a model where arrested receptors are as- 
sociated mainly with a cytochalasin-insensitive pool of 
cytoskeletal elements. 
T  I-IE neutrophil granulocyte has a distinguished capac- 
ity to sense and actively move along a concentration 
gradient of chemotactic peptide excreted by invading 
bacteria (Zigmond, 1977; Gallin,  1988). When the neutro- 
phil arrives at the site of infection, high concentrations (0.1-1 
#M) of chemotactic peptide lead to cellular arrest, degranu- 
lation and activation of neutrophil bactericidal systems, e.g., 
production of oxidative metabolites (Snyderman and Pike, 
1984; Gallin,  1988; Omann and Sklar,  1988). 
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The neutrophil  receptor for chemotactic bacterial  N-for- 
myl peptides, the f-Met-Leu-Phe (fMLF)~ receptor (Schiff- 
man, 1975; Becker, 1979; Snyderman and Pike, 1984; Bou- 
lay, 1990a,b) and its complex signal transducing system has 
been studied intensively (Snyderman  and Uhing, 1988; Jesai- 
tis and Allen, 1988). The signal has been proposed to be 
G-protein-dependent  (Jesaitis et al.,  1989; Sarndahl et al., 
1989; Bommikanti et al., 1992), and to include activation of 
phospholipase C (Martin, 1989) and protein kinase C (Helf- 
1.  Abbreviations  used in  this paper:  Boc-FLFLF,  tert-butyloxycarbonyl- 
Phe(D)-Leu-Phe(D)-Leu-Phe-OH;  dhcB,  dihydrocytochalasin  B;  fMLF, 
formyl-methionyl-leucyl-phenylalanine;  fnLLFnLYK,  formyl-Nle-Leu- 
Phe-Nle-Tyr-Lys; KRG, Krebs-Ringer  glucose phosphate buffer containing 
10 mM glucose and 1 mM Ca  2+ and Mg  2+, pH 7.3; NBT, p-nitroblue tetra- 
zolium chloride. 
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phosphates  and diacylglycerols (Berridge,  1987),  and cal- 
cium  mobilization  (Lew,  1989;  Baggiolini  and  Wymann, 
1990). 
Upon  activation,  there  is  compelling  biochemical  evi- 
dence of a redistribution  of receptors from membrane do- 
mains rich in G-proteins to areas depleted of G-proteins but 
rich in cytoskeletal elements, preferably actin (Jesaitis et al., 
1989).  Receptor-actin  interaction  has  been proposed as a 
shut-off mechanism for the signal, before receptor internal- 
ization. This notion is supported by the findings that formyl 
peptide is a potent inducer of neutrophil  actin polymeriza- 
tion (Jesaitis et al.,  1986; Bengtsson et al.,  1986). 
To investigate the lateral mobility characteristics and dis- 
tribution of the neutrophil formyl peptide receptor indepen- 
dently  of receptor  activation,  a  new  fluorescent  receptor 
antagonist  was synthesized,  viz.  fluoresceinated tertbutyl- 
oxycarbonyl-Phe(D)-Leu-Phe(o)-Leu-Phe-OH (Boc-FLFLF; 
Freer et al.,  1980). It was compared to a fluorescent recep- 
tor agonist (formyl-Nle-Leu-Phe-Nle-Tyr-Lys (fnLLFnLYK; 
Niedel et al.,  1979). 
Receptor lateral  mobility was measured using the tech- 
nique of fluorescence recovery after photobleaching (Jacob- 
son et al.,  1976; Johansson et al.,  1987). The experiments 
were performed at 14°C, which blocks receptor internaliza- 
tion (SEar  et al.,  1984).  Receptor specificity, distribution 
and  internalization  was studied  with  confocal microscopy 
(.~,slund et al.,  1987; Carlsson and/~slund,  1987). The oxi- 
dative response to the ligands was determined with a chemi- 
luminescence  assay (Dahlgren,  1987) and as reduction of 
p-nitroblue  tetrazolium  chloride  (NBT;  Baehner  et  al., 
1976). 
The results show that human neutrophil N-formyl peptide 
receptors occupied with active ligand aggregate and become 
immobilized in the neutrophil plasma membrane before in- 
ternalization;  a process that is affected, but not significantly 
reversed, by cytochalasin. 
To our knowledge, this is the first study using fluorescence 
recovery after photobleaching and confocal microscopy to 
address this question. 
Materials and Methods 
Chemicals 
Tert-butyl-oxycarbonyl-Phe(D)-Leu-Pbe(D)-Leu-Phe-OH  (Boc-FLFLF) was 
obtained from Sigma Chemical Co. (St Louis, MO) and conjugated to FITC 
by Molecular Probes Inc. (Eugene, OR). Molecular Probes Inc. also pro- 
vided fluoresceinated formyl-Nle-Leu-Phe-Nle-'Dyr-Lys  (fnLLFnLYK). Di- 
hydrocytochalasin B (dhCB),  Luminol, NBT and fMet-Leu-Phe (fMLF) 
were purchased from Sigma Chemical Co. HRP and BSA were obtained 
from Boehringer Mannheim GmbH (Mannheim, Germany). 
The peptides were stored frozen as stock solutions in small portions, 
Boc-FLFLF and fnLLFnLYK at -70°C and fMLF at -20°C. Before use, 
they were diluted in Krebs-Ringer phosphate buffer pH 7.3, containing lO 
mM glucose and  1 mM Ca  2+ and Mg  2+ (KRG). 
Cells 
Human neutrophils were obtained by two methods. Fingertip blood (two 
drops) was allowed to coagulate at 37°C for 30 min on a clean glass micro- 
scope slide with wells (Novakemi, Sweden), placed in a wet chamber. The 
blood clot was carefully washed off with KRG. At least 95 % of the glass- 
adherent cells were neutrophils. Alternatively, neutrophils were purified 
from heparinized venous blood by sedimentation, first on Macrodex (LKB- 
Pharmacia Biotechnology, Uppsala, Sweden) at room temperature and then 
on a  Ficoll-Paque gradient according to B~yum (1968).  The cells were 
washed twice in Ca  2+ and Mg2+-frea  KRG by centrifugation at 4°C and 
resuspended in KRG. 50 #1 of 5  ×  106 cells/ml were allowed to adhere to 
BSA (0.5 %, wt/wt) coated glasses for 30 rain at 37°C in a wet chamber. 
The glasses were finally washed gently in KRG. 
N-formyl Peptide Receptor Labeling 
50 #l of ice-cold fluorescent agonist (fnLLFnLYK) and antagonist (Boc- 
FLFLF) at 1 orO.1/zM in KRG was added to the glass-adherent neutrophils, 
precooled on ice for 10 rain in a humid chamber. A coverslip was placed 
over the well with the cells, forming a chamber which was sealed on ice 
with a hot wax-vaseline mixture (l:l). Receptor mobility measurements and 
confocal microscopy started within 5 rain after labeling including equilibra- 
tion to the desired temperature, and were completed within 30 rain (confo- 
cal microscopy) or 45-60 rain (FRAP). 
Cytochalasin Treatment 
Before labeling, the neutrophils were preincubated for 10 rain at 37°C in 
a humid chamber with 5 #M dhCB in KRG. The fluorescent fMLF agonist 
fnLLFnLYK was diluted in buffer containing 5 #M dhCB as a final concen- 
tration. Control cells were preincubated with buffer only. 
Acid Elution of  Surface-bound Ligand 
A method where low extracellular pH elutes surface-bound ligand, while 
leaving intracellular ligand intact (Sklar et al.,  1982;  O'Shea et al.,  1985; 
Bengtsson et al., 1991) was used to estimate the degree of receptor internal- 
ization. KRG was adjusted to pH 3.5 by addition of 5 M HCI (KRGpm.s). 
After labeling with fluorescent peptide at 4"C and a  15 rain incubation at 
14 or 37°C, the glass-adherent cells were mounted in KRGpH3.5 and exam- 
ined with the confocal microscope. 
Chemiluminescence Measurements 
Chemiluminescence was measured in a six-channel Biolumat LB9505 (Ber- 
thold Co,, Wildbad, FRG), Briefly, purified neutrophils were suspended in 
KRG to 0.25  x  106/ml with 0.1 mg/mi Luminol and 4 U/nil HRi  and pre- 
heated to 37°C for 5 rain. The reaction mixture (1 ml) was then subjected 
to fMLF (0.1 #M, final concentration), fluoresceina~xi fnLLFnLYK (0.01 
#M) or fluoresceinated Boc-FLFLF (0.1 #M). Furthermore, to ensure that 
the antagonist and the agonists competed for the same receptor, Boc-FLFLF 
(0.1-1  #M)  was added at maximal fMLF and fnLLFnLYK-induced che- 
miluminescence. Light emission was recorded continuously  (Dahlgren, 
1987). 
Reduction of  p-Nitroblue Tetrazolium Chloride 
To estimate the degree of activation of the neutrophil oxidase in the ex- 
perimental set-ups, reduction of NBT was used (Baehner et al.,  1976).  In 
the presence of  oxidative metabolites, NBT (yellow) is reduced to formazan 
(blue). BOC-FLFLF  (0.1 #M) or fnLLFnLYK (0.1 #M) in an 0.85 mg/ml 
NBT solution (PBS) was added to glass-adherent cells equilibrated to 14 
and 37°C, respectively, and the cells were further incubated for 30 min. 
KRG, fMLF (0.1 #M) and PMA (0.1 #M) were used as controls. 
Fluorescence Recovery after Photobleaching 
The equipment used has been described in detail elsewhere (Johansson et 
al.,  1987).  Briefly,  it is computer menu-driven and allows measurements 
of either of continuous fluorescence microphotolysis (Peters et al.,  1981) 
or FRAP (Peters et al., 1974; Jacobson et al., 1976; Axelrod et al., 1976). 
A SLOW-FRAP protocol suitable for protein diffusion studies was used (Jo- 
hansson et al.,  1987). 
The cell membrane was illuminated and photobleached (xl00-1,000 in- 
tensity) with an Argon laser (Type 2020-03,  Spectra Physics, Mountain 
View, CA) at 488 nm through a 160-/~m circular aperture ofa Zeiss Univer- 
sal  microscope (Carl  Zeiss,  Oberkocben,  FRG)  equipped with an  epi- 
fluorescence condenser for HTC-activation and an x63 oil-immersion  plan 
achromatic objective, which gives an estimated bleach spot radius (w) of 
0.89 #m at  1/e  2 intensity. 
The lateral diffusion coefficient (D) was calculated according to Axelrod 
et al. (1976) and the percent recovery (R), reflecting the proportion of mo- 
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SLOW-FRAP protocol used allowed us to first measure the fluorescence in 
the spot before bleaching (Fi), bleach (150-300 ms) and then sample the 
recovery of fluorescence in the bleached spot at time intervals of increasing 
length (e,g., from 1 to  10 s with a  final measurement, F=, at 60 s). 
To  avoid  cell  locomotion  and  prevent  internalization  of the  fMLF- 
receptor (Sklar et al., 1984), glass-adherent cells were kept at 14°C during 
the experiments using a temperature-regulated microscope stage. 
Confocai Microscopy 
A  Sarastro  1000  microscope  (Molecular  Dynamics,  Sunnyvale,  CA) 
(/~slund et al., 1987; Carlsson and/kslund, 1987) equipped with an Argon 
laser and a  xl00, high numeric aperture (1.4) objective (Nikon, Japan) was 
used. 
Neutrophils,  isolated and prepared as for FRAP measurements, were 
transported on ice and were,  for the study, kept at  14 or 37°C, using a 
temperature-regulated  (Peltier-type)  microscope  stage  (Detrona  AB, 
Linkfping, Sweden). Cells were chosen randomly in white light and optical 
~ectioning made in fluorescent light (488 nm line). To localize the cells after 
!ow pH elution of ligand, pictures were made using the white light source 
of the microscope. 
Statistical Methods 
Estimates of p-values were  obtained  using t  test  (Kirkwood,  1991).  A 
significant difference between two means has a two-sided p-value <0.05. 
Results 
Receptor Specificity and Capacity of the Antagonist 
and Agonist to Activate an Oxidative Burst 
The N-formyl peptide receptor specificity of fluoresceinated 
fnLLFnLYK is well established (Niedel et al.,  1979).  In- 
cidentally, this compound is a more potent activator of the 
neutrophil oxidative burst than fMLF (Skiar et al., 1985; Ta- 
ble I and Fig.  1). 
Preservation of the receptor specificity of the antagonist 
Boc-FLFLF (Freer et al., 1980) after FITC-conjugation was 
shown in two ways. First, a rapid, distinct reduction of the 
oxidative response was observed after addition of fluorescei- 
nated Boc-FLFLF to either fMLF- or fnLLFnLYK-stimu- 
lated cells at maximal chemiluminescence (Fig. 1). Second, 
addition of a 10-fold excess of fMLF to cells labeled with 0.1 
Table I.  Production of Oxidative Metabolites in 
Glass-adherent Human Neutrophils Measured as 
Reduction of p-Nitroblue  Tetrazolium Chloride 
Temperature 
Stimulus  14°C  370C 
none  -  - 
Boc-FLFLF 0.1  /~M  -  - 
fMLF 0.1  /~M  -  +(+) 
fnLLFnLYK 0.1  ttM  -  +  + 
fnLLFnLYK 0.1  /~M  +  dhcB 5/~M  -  +  + 
PMA 0.1  /zM  -  +++ 
Glass-adherent human neutrophils were subjected to  100/~1 of 0.1 /~M Boc- 
FLFLF, fnLLfnLYK, fMLF, or PMA (positive control) together with 0.85 mg/ml 
p-nitroblue tetrazolium chloride (Nffr) and incubated at the desired tempera- 
tore for 30 rain. DhcB-treated cells were preincubated with 5/zM dhcB for 10 
min at 37"C. The reaction was stopped by addition of 4% paraformaldehyde 
(PFA) at 40C. The degree of activation of the respiratory burst was estimated 
from the percentage of  blue cells due to fo~ formation (NBT-positive cells). 
+ + +, >95% positive cells;  -,  <5% positive cells. At least 200 cells were 
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Figure 1. Production of oxidative metabolites in non-adherent hu- 
man neutrophils upon binding of  agonists (fMLE fnLLFnLYK) and 
antagonist  (Boc-FLFLF)  to the N-formyl peptide receptor.  Lu- 
minol-amplified chemiluminescence in human neutrophils (37°C) 
in response to 0.01/~M fluoresceinated  receptor agortist  fnLLFnLYK 
(a, b, and c), to 0.1 /~M fMLF (d and e) and to 0.1 #M fluores- 
ceinated receptor antagonist Boc-FLFLF (f), added at point 1. The 
fluoresceinated antagonist (Boc-FLFLF), at 0.1/zM (b) or 1/~M (c 
and e) was also added at maximal agonist-induced chemilumines- 
cence (point 2). The figure shows a set of  curves from one represen- 
tative experiment of a total of 5-10. 
/zM  of  the  fluoresceinated  antagonist  obliterated  cell- 
associated fluorescence at 14°C (Fig. 2). 
Fluorescent Boc-FLFLF (0.1/zM) induced no chemilumi- 
nescence and no reduction of NBT at 37°C, confirming the 
antagonistic nature of the labeled compound (Table I  and 
Fig.  1). 
Reduction of NBT in glass-adherent cells further revealed 
that no activation of  the neutrophil oxidase occurred in glass- 
adherent cells at 14°C in response to 0.1 #M fnLLFnLYK, 
fMLF or PMA,  respectively (Table I). 
N-formyl Peptide Receptor Distribution and 
Internalization 
For neutrophils fluorescently labeled with the receptor an- 
tagonist Boc-FLFLF (0.1/zM) an almost uniform membrane 
distribution  of N-formyl peptide  receptors was  observed. 
The receptor distribution did not significantly change when 
the temperature was increased from 14 to 37°C, and no inter- 
nalization was detected (Figs. 4, 5, and 6). 
A  strikingly different lateral distribution of the receptor 
was seen at 14°C in cells fluorescently labeled with 0.1 #M 
of the receptor agonist fnLLFnLYK. It was evident that the 
agonist induced a lateral clustering of the receptors in the 
neutrophil plasma membrane at temperatures suboptimal for 
oxidase activation and N-formyl peptide receptor internaliza- 
tion (Figs. 4 and 5). At 37°C, receptor internalization was 
obvious in agonist-labeled cells (Fig. 6). 
Neutrophils pretreated with and maintained in 5/~M di- 
hydrocytochalasin B (dhcB) still displayed a patchy distribu- 
tion  of agonist-labeled  receptors  at  14°C.  However,  the 
receptor clusters in dhcB-treated cells (Fig. 4, g-i) appeared 
less well developed compared to cells not treated with dhcB, 
which  displayed a  less  diffuse, but more highly punctate 
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Peptide Receptor 
Around 60%  of the receptors  for fMLF appeared laterally 
mobile in neutrophils  labeled  with antagonist,  i.e.,  40% of 
the receptors were immobile. The mobile fraction of recep- 
tors,  R, decreased  significantly,  to ~40%,  in cells labeled 
with the agonist fnLLFnLYK. 
Treatment with 5/~M dhcB did not significantly  affect the 
Figure 2. Competitive inhibition of the binding of fluorescent N-for- 
myl peptide receptor antagonist by fMLF.  Glass-adherent neutro- 
phils, labeled at 4°C with 0.1 #M of the fluorescent receptor antag- 
onist Boc-FLFLE were mounted in buffer containing 1/.¢M fMLF 
(a), or in buffer only (b) and examined in the confocal microscope 
at  14°C.  Bar, 5  yM. 
receptor distribution (Fig. 4, d-f). Moreover, at 37°C, along 
with large fluorescent  clusters,  agonist-labeled  cells showed 
more internal  diffuse fluorescence (Fig.  6 d) compared  to 
cells treated with dhcB  (Fig.  6 g). 
Table II. Lateral Mobility at 14°C of the 
N-formyl Peptide Receptor in Individual Human 
Neutrophils Labeled with Antagonistic and 




n  D  R 
x 10  -z° cmZ/s  % 
1 #M  12  5.4  +  0.3  63  +  3 
(5.2)  (65) 
0.1  #M  29  4.7  +  0.5  57  +  5* 
(4.8)  (57) 
0.1  /~M  16  5.5  +  0.3  40  +  3* 
(6.0)  (38) 
0.1  tzM  +  21  5.6  +  0.3  44  +  2 
dhcB 5  #M  (5.6)  (46) 
* p < 0.001.  Glass-adherent human neutrophils were fluorescently labeled at 
4"C with either a N-formyl peptide receptor antagonist (Boc-FLFLF) or an 
agonist (fnLLFnLYK). Measurements of receptor lateral mobility were done 
at 14"C using the FRAP technique. The effect of 5/~M dihydrocytochalasin 
B (dhcB) on the lateral mobility of the agonist-labeled fMLF-receptor was also 
assessed.  D is the diffusion coefficient, R the fraction of mobile receptors. 
Mean values are given + SEM with median values in parenthesis, n is the num- 
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Figure 3.  Lateral mobility of antagonist and agonist-labeled N-for- 
myl peptide receptor in individual neutrophils, effect of cytochala- 
sin. Diffusion constant, D, and mobile fraction, R, of the N-formyl 
peptide  (fMLF)  receptors  in individual human neutrophils mea- 
sured with fluorescence recovery after photobleaching (FRAP) at 
14°C. Neutrophils were labeled at 4°C with 1 or 0.1/~M of receptor 
antagonist (Boc-FLFLF)  or 0.1  I~M of receptor agonist (fnLLn- 
LYK). The agonist-labeled cells in the last lane were further treated 
with 5 #M dihydrocytochalasin B (dhcB). Solid line indicates mean 
value (Table 1/). 
The Journal of Cell Biology, Volume 121, 1993  1284 Figure 4. Distribution of antagonist and agonist-labeled N-formyl peptide receptors in human neutrophils at 14°C, effect of eytochalasin. 
Glass-adherent human neutrophils were examined in the confocal fluorescence microscope at 14"C after labeling at 4°C with 0.1 #M recep- 
tor antagonist (Boc-FLFLF; a-c), or 0.1 #M receptor agonist (fnLLFnLYK; d-i). The cells in g-i were preincubated, and maintained, 
in 5 #M dihydrocytochalasin B (dhcB) during labeling and examination. Optical sections at increasing depth are shown in a-c, d-f and 
g-i.  Distance between sections was 2 #m. Bar, 5 #m. 
size of the mobile fraction in agonist-labeled cells (Table II). 
However, there was evidence of a shift in the distribution of 
R values of the cytochalsin-treated cells towards the mean 
value of  antagonist-treated cells (Fig. 3). This effect was even 
more evident from the median values (Table ID. 
The lateral diffusion coefficient (D) of the mobile fraction 
of N-formyl peptide  receptors  was  similar  regardless  of 
whether the cells had been labeled with receptor agonist or 
antagonist,  and was found to be around 5  x  10  -10 cm2/s. 
The diffusion constant was not significantly affected by dhcB 
treatment (Table II, Fig. 3). 
Discussion 
This is, to our knowledge, the first conclusive study of the 
N-formyl peptide receptor distribution and lateral mobility 
in the neutrophil membrane (compare Biiltmann et al., 1987; 
McKay et al., 1991), using FRAP and confocal microscopy. 
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membrane-bound  ligand  at 
14"C in human neutrophils la- 
beled with antagonist and ago- 
nist to the N-formyl peptide 
receptor, effect  of  cytochalasin. 
Glass-adherent human neutro- 
phils,  mounted  in  KRGpm.5, 
were examined in the confocal 
microscope at  140C after la- 
beling  at  4°C  with  0.1  #M 
receptor  antagonist  (Boc- 
FLFLF; a-b), or 0.1 #M re- 
ceptor agonist (fnLLFnLYK; 
c-f).  The cells  in  e-f were 
preincubated, and maintained, 
in 5 ~M dihydrocytochalasin 
B (dhcB) during labeling and 
examination, a, c, and e were 
recorded using the white light 
source of the confocal micro- 
scope,  b,  d,  and f  show the 
corresponding confocal fluo- 
rescence image to a, c, and e, 
respectively. Bar, 5 #m. 
Moreover,  and  in  contrast  to  the  agonist  fnLLFnLYK 
(Niedel et al.,  1979; Sklar et al.,  1982, 1984; Seligmann et 
al., 1984; Walter and Marasco, 1987; Biiltmann et al., 1987; 
Schmitt and Biiltmann,  1990), the antagonist Boc-FLFLF 
(Freer et al., 1980) has not previously been used as a fluores- 
cent receptor label. 
The combination of BOC-FLFLF and  fnLLFnLYK pro- 
vided a straightforward way to follow the effects of activation 
on the N-formyl peptide receptor lateral mobility and distri- 
bution. An advantage with these small-sized labels was also 
that  they would,  theoretically, not by themselves restrain 
receptor lateral diffusion. 
FnLLFnLYK is a potent inducer of the neutrophil respira- 
tory burst, both in cells in solution (Sklar et al.,  1982; Fig. 
1) and cells attached to glass (Table I). At 37°C it is rapidly 
internalized together with the N-formyl  peptide receptor. Be- 
low 15°C, internalization is blocked (SEar et al., 1984; Figs. 
4 and 5). At this temperature, there is also no activation of 
the neutrophil oxidase, resulting in production of oxidative 
metabolites (Jesaitis et al.,  1986; Table I). 
At 15°C the N-formyl  peptide receptor nevertheless under- 
goes an activation-specific change in ligand affinity (Jesaitis 
and Allen,  1988) and there is evidence that the receptors 
shift from areas rich in G-proteins to membrane domains in 
The Journal of Cell Biology,  Volume 121, 1993  1286 Figure 6. Distribution of antagonist and agonist-labeled N-formyl peptide receptors in human neutrophils at 37°C, effect of cytochalasin. 
Acid elution of membrane-bound ligand. Glass-adherent human neutrophils were examined in the confocal microscope at 370C after label- 
ing at 4°C with 0.1 /zM receptor antagonist (Boc-FLFLF; a-c), or 0.1 #M receptor agonist (fnLLFnLYK; d-i). The cells in g-i were 
preincubated, and maintained in 5 #M dihydrocytochalasin B (dhcB) during labeling and examination, b-c, e-f  and h-i show cells mounted 
in KRGort3.5. b, e, and h were recorded using the white light source of the confocal microscope, c, f, and i show the corresponding confo- 
ca1 fluorescence images to b, e, and h, respectively  Bar, 5/~m. 
close contact with cytoskeletal elements,  preferably actin 
(Jesaitis et al.,  1989; Klotz, K. N., D.  Siemsen, and A. J. 
Jesaitis.  1991. J.  Cell Biol.  115:3a.  [Abstr.]). 
In this study we observed a distinct clustering of N-formyl 
peptide receptors at  14°C induced by the receptor agonist 
FnLLFnLYK  (Fig.  4).  This  finding  was  paralleled  by  a 
significant reduction of the fraction of mobile receptors, R, 
in the membrane (Table II, Fig.  3). 
This reduction of R was reversed, albeit not significantly, 
towards the R  values of antagonist-labeled cells (Table II, 
Fig.  3) by dihydrocytochalasin B  (dhcB),  which normally 
blocks actin polymerization (Lin et al., 1977, 1982). In addi- 
tion, the receptor clusters formed in dhcB-treated ceils at 
14°C  appeared less  well developed compared to agonist- 
labeled controls (Fig.  4).  Moreover, at 37°C dhcB-treated 
cells displayed less internal diffuse fluorescence than con- 
trois (Fig. 6). 
These findings could suggest that dhcB has an effect on the 
internalization rate of  the agonist-labeled receptor and possi- 
bly on the rate of formation of clusters. They would be in ac- 
cordance with  the  results  reported by Jesaitis  and  Allen 
(Jesaitis and Alien, 1988), where formation of receptor high 
affinity Triton X-100 insoluble complexes was slowed, but 
not completely inhibited, by dhcB-treatment. The kinetics of 
Johansson et al. Distribution and Mobility of  fMLF Receptors  1287 cluster formation and receptor internalization under differ- 
ent  circumstances  remains  to  be  examined  in  a  separate 
study. 
We found that the diffusion constant, D, of the mobile frac- 
tion of receptors  was =5  x  1O  -~° cm2/s at  14°C (Table II, 
Fig.  3), which is typical for an intrinsic membrane protein 
(Jacobson,  1983).  The  diffusion constant was not signifi- 
cantly influenced by receptor occupation with active ligand 
(Table II, Fig. 3). This suggests that the proposed interaction 
between  activated  N-formyl  peptide  receptors  and  the 
cytoskeleton, turning off the signal (Jesaitis et al.,  1986), is 
an all-or-nothing effect, immobilizing receptors completely. 
Incidentally,  when  discussing  the  relationship  between 
receptor mobility and cellular activation, Jesaitis and Allen 
(1988)  assumed  a  theoretical  N-formyl  peptide  receptor 
diffusion constant of between  1 and  10  x  10  -t0 cm2/s. We 
can now substantiate these calculations, by assigning a value, 
=5  x  10  -'° cm2/s, tO the rate of diffusion of the neutrophil 
N-formyl peptide receptor. 
Taken together, the results indicate that before receptor in- 
ternalization,  and in the absence of activation of the neutro- 
phil oxidase, N-formyl peptide receptors occupied by active 
ligand are laterally  redistributed,  aggregated and immobi- 
lized in the neutrophil plasma membrane by a process appar- 
ently affected by, but not entirely dependent on, actin poly- 
merization. 
There is, however, evidence of a cytochalasin-insensitive 
pool of actin in neutrophils (Cassimeris et al.,  1990).  Our 
results may indicate that this pool of actin, or other cytoskel- 
eta] components,  are involved in receptor  immobilization. 
Incidentally, there are recent data that suggest that the inter- 
action between N-formyl peptide receptors and the neutro- 
phil cytoskeleton  is in fact mainly cytochalasin-insensitive 
(K.  N.  Klotz  and A.  J.  Jesaitis,  personal communication; 
Klotz,  K. N.,  D. Siemsen, and A. J. Jesaitis.  1991. J.  Cell 
Biol.  115:3a.  [Abstr.]). 
The response to N-formyl peptide  in suspended neutro- 
phils (Sklar et al.,  1984; Jesaitis et al.,  1986; Bengtsson et 
al.,  1986; Jesaitis and Allen,  1988; Omann and Sklar,  1988; 
Jesaitis et al.,  1989) might, in addition, differ from cells at- 
tached to glass. Cytokines, such as TNF and CSF-GM, actu- 
ally fail to evoke an oxidative response in nonadherent cells 
(Nathan et al., 1987, 1989a,b). This absolute dependency on 
adherence is not true for the N-formyl peptide receptor, but 
modifications of the cellular response cannot be ruled out. 
Finally, we anticipate that the method of receptor labeling 
outlined in this work, using pairs of fluorescent agonists and 
antagonists,  is applicable to studies of lateral mobility and 
distribution of receptors in a variety of cell  systems. 
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